Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Lopez-Yurda, M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(12)
+
-
Availability
Open access
(6)
+
-
Under embargo
(1)
+
-
Metadata Only
(5)
+
-
Creation Date
2023
(4)
+
-
2016
(2)
+
-
2022
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Scholarly Publications
(5)
+
-
Topic
head and neck cancer
(2)
+
-
Author
Lopez-Yurda, M.
(12)
+
-
Balm, A.J.M.
(4)
+
-
Boer, J.P. de
(3)
+
-
Baan, S. van der
(2)
+
-
Cats, A.
(2)
+
-
Dreschler, W.A.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hauptmann, M.
(2)
+
-
Knikman, J.E.
(2)
+
-
Mathijssen, R.H.J.
(2)
+
-
Meulendijks, D.
(2)
+
-
Rasch, C.R.
(2)
+
-
Rasch, C.R.N.
(2)
+
-
Schellens, J.H.M.
(2)
+
-
Tan, I.B.
(2)
+
-
Theunissen, E.A.R.
(2)
+
-
Zuur, C.L.
(2)
+
-
Show more
Language
en
(12)
+
-
Search results
(1 - 12 of 12)
show grid
show list
save search
The predictive value of FDG PET/CT for determining progression-free survival in advanced stage III-IV BRAF-mutated melanoma patients treated with targeted therapy
Survival of patients with cancer with DPYD variant alleles and dose-individualized fluoropyrimidine therapy
A nomogram to predict severe toxicity in DPYD wild-type patients treated with capecitabine-based anticancer regimens
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients
Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma
Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE)
Irradiation of localized squamous cell carcinoma of the nasal vestibule
Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
Long-Term Hearing Loss After Chemoradiation in Patients With Head and Neck Cancer
Do Rectal Cancer Patients with PIK3CA Mutations Benefit from Preoperative Radiotherapy with Regard to Local Recurrences?